Feature Enhancement

When doing stock checks and the medication numbers correlate it would be beneficial and a time saver to have a button that says "stock correct". Currently it's a very convoluted system with lots of clicks just to say the level matches the system n...

To stop the screen from rotating when using Atlas eMAR on the Zebra device. If rotation is turned off in the device settings it does not seem to pull through in the Atlas eMAR app.

Our home policy states we require two signature when booking in and returning medication. I am sure most other care services are the same. Could this be reviewed to add to the system.

This will help us to evidence that a medication is administered covertly

It would be really useful if the option to add a generic protocol for each medication was available rather than having to add for every single resident.

Having a covert administration medication code, such as administered covertly and refused covertly. This would help by not having to remember to go back and write a note as this can sometimes lead to not being done on time which then doesn't refle...

We’ve found the current workflow of maintaining paper MAR charts for homely remedies while using ATLAS for all other medications to be quite counterintuitive. As our service keeps a single shared homely remedies box—and residents do not have indiv...

The current Atlas eMAR system lacks a dedicated function to define the form of medication when adding supplements. As a result: Supplements are inconsistently recorded – some are entered in quantity (e.g., tablets), others in mls (e.g., liquids). ...

When generating a report and wanting to print you have to use the Export/Print option. You are then left with a Excel Spreadsheet to adjust yourself. Can these be generated as a pdf to look like what is on the screen?

The addition of an optional “Second Witness Required” tick box to the Add Drug screen within Atlas eMAR. This feature would enable services to designate individual medications—outside of standard Controlled Drug protocols—as requiring a second sta...